全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
PLOS ONE  2013 

Salinomycin Activates AMP-Activated Protein Kinase-Dependent Autophagy in Cultured Osteoblastoma Cells: A Negative Regulator against Cell Apoptosis

DOI: 10.1371/journal.pone.0084175

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background The malignant osteoblastoma has poor prognosis, thus the search for novel and more efficient chemo-agents against this disease is urgent. Salinomycin induces broad anti-cancer effects both in vivo and in vitro, however, its role in osteoblastoma is still not clear. Key Findings Salinomycin induced both apoptosis and autophagy in cultured U2OS and MG-63 osteoblastoma cells. Inhibition of autophagy by 3-methyladenine (3-MA), or by RNA interference (RNAi) of light chain 3B (LC3B), enhanced salinomycin-induced cytotoxicity and apoptosis. Salinomycin induced a profound AMP-activated protein kinase (AMPK) activation, which was required for autophagy induction. AMPK inhibition by compound C, or by AMPKα RNAi prevented salinomycin-induced autophagy activation, while facilitating cancer cell death and apoptosis. On the other hand, the AMPK agonist AICAR promoted autophagy activation in U2OS cells. Salinomycin-induced AMPK activation was dependent on reactive oxygen species (ROS) production in osteoblastoma cells. Antioxidant n-acetyl cysteine (NAC) significantly inhibited salinomycin-induced AMPK activation and autophagy induction. Conclusions Salinomycin activates AMPK-dependent autophagy in osteoblastoma cells, which serves as a negative regulator against cell apoptosis. AMPK-autophagy inhibition might be a novel strategy to sensitize salinomycin’s effect in cancer cells.

References

[1]  Ham SJ, Schraffordt Koops H, van der Graaf WT, van Horn JR, Postma L et al. (1998) Historical, current and future aspects of osteosarcoma treatment. Eur J Surg Oncol 24: 584-600. doi:10.1016/S0748-7983(98)93896-3. PubMed: 9870738.
[2]  Zardawi SJ, O'Toole SA, Sutherland RL, Musgrove EA (2009) Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer. Histol Histopathol 24: 385-398. PubMed: 19130408.
[3]  Michaelson MD, Smith MR (2005) Bisphosphonates for treatment and prevention of bone metastases. J Clin Oncol 23: 8219-8224. doi:10.1200/JCO.2005.02.9579. PubMed: 16278476.
[4]  Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C et al. (2009) Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138: 645-659. doi:10.1016/j.cell.2009.06.034. PubMed: 19682730.
[5]  Riccioni R, Dupuis ML, Bernabei M, Petrucci E, Pasquini L et al. (2010) The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor. Blood Cells Mol Dis 45: 86-92. doi:10.1016/j.bcmd.2010.03.008. PubMed: 20444629.
[6]  Fuchs D, Daniel V, Sadeghi M, Opelz G, Naujokat C (2010) Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells. Biochem Biophys Res Commun 394: 1098-1104. doi:10.1016/j.bbrc.2010.03.138. PubMed: 20350531.
[7]  Lu D, Choi MY, Yu J, Castro JE, Kipps TJ et al. (2011) Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells. Proc Natl Acad Sci U S A 108: 13253-13257. doi:10.1073/pnas.1110431108. PubMed: 21788521.
[8]  Kim KY, Yu SN, Lee SY, Chun SS, Choi YL et al. (2011) Salinomycin-induced apoptosis of human prostate cancer cells due to accumulated reactive oxygen species and mitochondrial membrane depolarization. Biochem Biophys Res Commun 413: 80-86. doi:10.1016/j.bbrc.2011.08.054. PubMed: 21871443.
[9]  Kim JH, Chae M, Kim WK, Kim YJ, Kang HS et al. (2011) Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein. Br J Pharmacol 162: 773-784. doi:10.1111/j.1476-5381.2010.01089.x. PubMed: 20973777.
[10]  Mihaylova MM, Shaw RJ (2011) The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 13: 1016-1023. doi:10.1038/ncb2329. PubMed: 21892142.
[11]  Luo Z, Saha AK, Xiang X, Ruderman NB (2005) AMPK, the metabolic syndrome and cancer. Trends Pharmacol Sci 26: 69-76. doi:10.1016/j.tips.2004.12.011. PubMed: 15681023.
[12]  Wang S, Song P, Zou MH (2012) AMP-activated protein kinase, stress responses and cardiovascular diseases. Clin Sci (Lond) 122: 555-573. doi:10.1042/CS20110625. PubMed: 22390198.
[13]  Codogno P, Meijer AJ (2005) Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ 12 Suppl 2: 1509-1518. doi:10.1038/sj.cdd.4401751. PubMed: 16247498.
[14]  Galluzzi L, Vicencio JM, Kepp O, Tasdemir E, Maiuri MC et al. (2008) To die or not to die: that is the autophagic question. Curr Mol Med 8: 78-91. doi:10.2174/156652408783769616. PubMed: 18336289.
[15]  Gozuacik D, Kimchi A (2004) Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23: 2891-2906. doi:10.1038/sj.onc.1207521. PubMed: 15077152.
[16]  Klionsky DJ, Emr SD (2000) Autophagy as a regulated pathway of cellular degradation. Science 290: 1717-1721. doi:10.1126/science.290.5497.1717. PubMed: 11099404.
[17]  Boya P, González-Polo RA, Casares N, Perfettini JL, Dessen P et al. (2005) Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol 25: 1025-1040. doi:10.1128/MCB.25.3.1025-1040.2005. PubMed: 15657430.
[18]  Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA et al. (2007) Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 117: 326-336. doi:10.1172/JCI28833. PubMed: 17235397.
[19]  Li J, Hou N, Faried A, Tsutsumi S, Takeuchi T et al. (2009) Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. Ann Surg Oncol 16: 761-771. doi:10.1245/s10434-008-0260-0. PubMed: 19116755.
[20]  Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA et al. (2011) Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331: 456-461. doi:10.1126/science.1196371. PubMed: 21205641.
[21]  Kim J, Kundu M, Viollet B, Guan KL (2011) AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 13: 132-141. doi:10.1038/ncb2152. PubMed: 21258367.
[22]  Tanida I, Ueno T, Kominami E (2004) Human light chain 3/MAP1LC3B is cleaved at its carboxyl-terminal Met121 to expose Gly120 for lipidation and targeting to autophagosomal membranes. J Biol Chem 279: 47704-47710. doi:10.1074/jbc.M407016200. PubMed: 15355958.
[23]  Seglen PO, Gordon PB (1982) 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci U S A 79: 1889-1892. doi:10.1073/pnas.79.6.1889. PubMed: 6952238.
[24]  Nezis IP, Stenmark H (2012) p62 at the interface of autophagy, oxidative stress signaling, and cancer. Antioxid Redox Signal 17: 786-793. doi:10.1089/ars.2011.4394. PubMed: 22074114.
[25]  Moscat J, Diaz-Meco MT (2011) Feedback on fat: p62-mTORC1-autophagy connections. Cell 147: 724-727. doi:10.1016/j.cell.2011.10.021. PubMed: 22078874.
[26]  Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA et al. (2007) p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282: 24131-24145. doi:10.1074/jbc.M702824200. PubMed: 17580304.
[27]  Komatsu M, Ichimura Y (2010) Physiological significance of selective degradation of p62 by autophagy. FEBS Lett 584: 1374-1378. doi:10.1016/j.febslet.2010.02.017. PubMed: 20153326.
[28]  Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G et al. (2009) Autophagy suppresses tumorigenesis through elimination of p62. Cell 137: 1062-1075. doi:10.1016/j.cell.2009.03.048. PubMed: 19524509.
[29]  Vicencio JM, Galluzzi L, Tajeddine N, Ortiz C, Criollo A et al. (2008) Senescence, apoptosis or autophagy? When a damaged cell must decide its path--a mini-review. Gerontology 54: 92-99. doi:10.1159/000129697. PubMed: 18451641.
[30]  Maiuri MC, Zalckvar E, Kimchi A, Kroemer G (2007) Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 8: 741-752. doi:10.1038/nrm2239. PubMed: 17717517.
[31]  Levine B, Yuan J (2005) Autophagy in cell death: an innocent convict? J Clin Invest 115: 2679-2688. doi:10.1172/JCI26390. PubMed: 16200202.
[32]  Inoki K, Kim J, Guan KL (2012) AMPK and mTOR in cellular energy homeostasis and drug targets. Annu Rev Pharmacol Toxicol 52: 381-400. doi:10.1146/annurev-pharmtox-010611-134537. PubMed: 22017684.
[33]  Sakoda H, Ogihara T, Anai M, Fujishiro M, Ono H et al. (2002) Activation of AMPK is essential for AICAR-induced glucose uptake by skeletal muscle but not adipocytes. Am J Physiol Endocrinol Metab 282: E1239-E1244. PubMed: 12006353.
[34]  Verdoodt B, Vogt M, Schmitz I, Liffers ST, Tannapfel A et al. (2012) Salinomycin induces autophagy in colon and breast cancer cells with concomitant generation of reactive oxygen species. PLOS ONE 7: e44132. doi:10.1371/journal.pone.0044132. PubMed: 23028492.
[35]  Li T, Su L, Zhong N, Hao X, Zhong D et al. (2013) Salinomycin induces cell death with autophagy through activation of endoplasmic reticulum stress in human cancer cells. Autophagy 9: 1057–68. PubMed: 23670030.
[36]  Jangamreddy JR, Ghavami S, Grabarek J, Kratz G, Wiechec E et al. (2013) Salinomycin induces activation of autophagy, mitophagy and affects mitochondrial polarity: Differences between primary and cancer cells. Biochim Biophys Acta 1832: 2057-2069. doi:10.1016/j.bbadis.2013.07.015. PubMed: 23906978.
[37]  Egan D, Kim J, Shaw RJ, Guan KL (2011) The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR. Autophagy 7: 643-644. doi:10.4161/auto.7.6.15123. PubMed: 21460621.
[38]  Hardie DG, Ross FA, Hawley SA (2012) AMP-Activated Protein Kinase: A Target for Drugs both Ancient and Modern. Chem Biol 19: 1222-1236. doi:10.1016/j.chembiol.2012.08.019. PubMed: 23102217.
[39]  Chen MB, Shen WX, Yang Y, Wu XY, Gu JH et al. (2011) Activation of AMP-activated protein kinase is involved in vincristine-induced cell apoptosis in B16 melanoma cell. J Cell Physiol, 226: 1915–25. PubMed: 21506122.
[40]  Kang MR, Park SK, Lee CW, Cho IJ, Jo YN et al. (2012) Widdrol induces apoptosis via activation of AMP-activated protein kinase in colon cancer cells. Oncol Rep 27: 1407-1412. PubMed: 22266984.
[41]  Zheng QY, Jin FS, Yao C, Zhang T, Zhang GH et al. (2012) Ursolic acid-induced AMP-activated protein kinase (AMPK) activation contributes to growth inhibition and apoptosis in human bladder cancer T24 cells. Biochem Biophys Res Commun, 419: 741–7. PubMed: 22387548.
[42]  Narbonne P, Roy R (2009) Caenorhabditis elegans dauers need LKB1/AMPK to ration lipid reserves and ensure long-term survival. Nature 457: 210-214. doi:10.1038/nature07536. PubMed: 19052547.
[43]  Jeon SM, Chandel NS, Hay N (2012) AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 485: 661-665. doi:10.1038/nature11066. PubMed: 22660331.
[44]  Chen L, Xu B, Liu L, Luo Y, Yin J et al. (2010) Hydrogen peroxide inhibits mTOR signaling by activation of AMPKalpha leading to apoptosis of neuronal cells. Lab Invest 90: 762-773. doi:10.1038/labinvest.2010.36. PubMed: 20142804.
[45]  Ji C, Yang YL, Yang Z, Tu Y, Cheng L et al. (2012) Perifosine sensitizes UVB-induced apoptosis in skin cells: new implication of skin cancer prevention? Cell Signal 24: 1781-1789. doi:10.1016/j.cellsig.2012.05.003. PubMed: 22584119.
[46]  Chen Z, Shen X, Shen F, Zhong W, Wu H et al. (2013) TAK1 activates AMPK-dependent cell death pathway in hydrogen peroxide-treated cardiomyocytes, inhibited by heat shock protein-70. Mol Cell Biochem 377: 35-44. doi:10.1007/s11010-013-1568-z. PubMed: 23378049.
[47]  Ketola K, Hilvo M, Hy?tyl?inen T, Vuoristo A, Ruskeep?? AL et al. (2012) Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress. Br J Cancer 106: 99-106. doi:10.1038/bjc.2011.530. PubMed: 22215106.
[48]  Yao C, Wu S, Li D, Ding H, Wang Z et al. (2012) Co-administration phenoxodiol with doxorubicin synergistically inhibit the activity of sphingosine kinase-1 (SphK1), a potential oncogene of osteosarcoma, to suppress osteosarcoma cell growth both in vivo and in vitro. Mol Oncol 6: 392-404. doi:10.1016/j.molonc.2012.04.002. PubMed: 22583777.
[49]  Yao C, Wei JJ, Wang ZY, Ding HM, Li D et al. (2013) Perifosine induces cell apoptosis in human osteosarcoma cells: new implication for osteosarcoma therapy? Cell Biochem Biophys 65: 217-227. doi:10.1007/s12013-012-9423-5. PubMed: 23015227.
[50]  Tsuboi R, Sato C, Kurita Y, Ron D, Rubin JS et al. (1993) Keratinocyte growth factor (FGF-7) stimulates migration and plasminogen activator activity of normal human keratinocytes. J Invest Dermatol 101: 49-53. doi:10.1111/1523-1747.ep12358892. PubMed: 8331296.
[51]  Chen MB, Wu XY, Tao GQ, Liu CY, Chen J et al. (2012) Perifosine sensitizes curcumin induced anti-colorectal cancer effects by targeting multiple signaling pathways both in vivo and in vitro. Int J Cancer.
[52]  Lee HM, Shin DM, Yuk JM, Shi G, Choi DK et al. (2011) Autophagy negatively regulates keratinocyte inflammatory responses via scaffolding protein p62/SQSTM1. J Immunol 186: 1248-1258. doi:10.4049/jimmunol.1001954. PubMed: 21160040.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133